Su Z - Search Results

1

Transforming Weakness into Strength: Photothermal-Therapy-Induced Inflammation Enhanced Cytopharmaceutical Chemotherapy as a Combination Anticancer Treatment.

Zhang L, Zhang Y, Xue Y, Wu Y, Wang Q, Xue L, Su Z, Zhang C. Zhang L, et al. Among authors: su z. Adv Mater. 2019 Feb;31(5):e1805936. doi: 10.1002/adma.201805936. Epub 2018 Dec 9. Adv Mater. 2019. PMID: 30537012

2

An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery.

Li S, Su Z, Sun M, Xiao Y, Cao F, Huang A, Li H, Ping Q, Zhang C. Li S, et al. Among authors: su z. Int J Pharm. 2012 Oct 15;436(1-2):248-57. doi: 10.1016/j.ijpharm.2012.06.040. Epub 2012 Jun 23. Int J Pharm. 2012. PMID: 22732672

3

Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.

Su Z, Xing L, Chen Y, Xu Y, Yang F, Zhang C, Ping Q, Xiao Y. Su Z, et al. Mol Pharm. 2014 Jun 2;11(6):1823-34. doi: 10.1021/mp500238m. Epub 2014 May 15. Mol Pharm. 2014. PMID: 24779677

4

ROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor's multidrug resistance.

Su Z, Chen M, Xiao Y, Sun M, Zong L, Asghar S, Dong M, Li H, Ping Q, Zhang C. Su Z, et al. J Control Release. 2014 Dec 28;196:370-83. doi: 10.1016/j.jconrel.2014.09.020. Epub 2014 Sep 30. J Control Release. 2014. PMID: 25278256

5

A Collaborative Assembly Strategy for Tumor-Targeted siRNA Delivery.

Sun Q, Kang Z, Xue L, Shang Y, Su Z, Sun H, Ping Q, Mo R, Zhang C. Sun Q, et al. Among authors: su z. J Am Chem Soc. 2015 May 13;137(18):6000-10. doi: 10.1021/jacs.5b01435. Epub 2015 May 4. J Am Chem Soc. 2015. PMID: 25869911

6

Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy.

Ge Z, Hao M, Xu M, Su Z, Kang Z, Xue L, Zhang C. Ge Z, et al. Among authors: su z. Eur J Med Chem. 2016 Jan 1;107:48-62. doi: 10.1016/j.ejmech.2015.10.042. Epub 2015 Nov 3. Eur J Med Chem. 2016. PMID: 26562542

7

Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.

He Y, Su Z, Xue L, Xu H, Zhang C. He Y, et al. Among authors: su z. J Control Release. 2016 May 10;229:80-92. doi: 10.1016/j.jconrel.2016.03.001. Epub 2016 Mar 3. J Control Release. 2016. PMID: 26945977

8

Reversing Cancer Multidrug Resistance in Xenograft Models via Orchestrating Multiple Actions of Functional Mesoporous Silica Nanoparticles.

Yang D, Wang T, Su Z, Xue L, Mo R, Zhang C. Yang D, et al. Among authors: su z. ACS Appl Mater Interfaces. 2016 Aug 31;8(34):22431-41. doi: 10.1021/acsami.6b04885. Epub 2016 Aug 16. ACS Appl Mater Interfaces. 2016. PMID: 27420116

9

Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.

Chen X, Zhang Y, Tang C, Tian C, Sun Q, Su Z, Xue L, Yin Y, Ju C, Zhang C. Chen X, et al. Among authors: su z. Int J Pharm. 2017 Aug 30;529(1-2):102-115. doi: 10.1016/j.ijpharm.2017.06.071. Epub 2017 Jun 19. Int J Pharm. 2017. PMID: 28642204

10

A modular assembly pH-sensitive charge reversal siRNA delivery system.

Sun Q, Tang C, Su Z, Du J, Shang Y, Xue L, Zhang C. Sun Q, et al. Among authors: su z. Biomater Sci. 2018 Nov 1;6(11):3075-3084. doi: 10.1039/c8bm01062e. Epub 2018 Oct 10. Biomater Sci. 2018. PMID: 30302460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,549 results

Search Page

Filters